APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Anesthesia

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhalation Anesthesia Market Outlook and Growth Opportunities 2026

19 December 2025197 pages

Choose your research edition.

Industry ResearchInhalation Anesthesia Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Anesthesia Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Inhalation Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Anesthesia Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Anesthesia Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation Anesthesia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhalation Anesthesia market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhalation Anesthesia market include Lunan Pharmaceutical Group Co.Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi Ag, Baxter, AbbVie Inc., Piramal Enterprises Limited, Hikma Pharmaceuticals PLC and Halocarbon Products Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Anesthesia market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Anesthesia and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Anesthesia sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Anesthesia market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Anesthesia Segment by Company

Lunan Pharmaceutical Group Co.Ltd.

Jiangsu Hengrui Medicine Co. Ltd.

Fresenius Kabi Ag

Baxter

AbbVie Inc.

Piramal Enterprises Limited

Hikma Pharmaceuticals PLC

Halocarbon Products Corporation

Inhalation Anesthesia Segment by Type

Isoflurane

Sevoflurane

Desflurane

Inhalation Anesthesia Segment by Application

Induction

Maintenance

Inhalation Anesthesia Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Inhalation Anesthesia status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhalation Anesthesia market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhalation Anesthesia significant trends, drivers, influence factors in global and regions.

6. To analyze Inhalation Anesthesia competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Anesthesia market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhalation Anesthesia industry.

Chapter 3: Detailed analysis of Inhalation Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhalation Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhalation Anesthesia in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhalation Anesthesia Industry Trends Table 2. Inhalation Anesthesia Industry Drivers Table 3. Inhalation Anesthesia Industry Opportunities and Challenges Table 4. Inhalation Anesthesia Industry Restraints Table 5. Global Inhalation Anesthesia Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhalation Anesthesia Revenue Share by Company (2021-2026) Table 7. Global Inhalation Anesthesia Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhalation Anesthesia Sales Volume Share by Company (2021-2026) Table 9. Global Inhalation Anesthesia Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhalation Anesthesia Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhalation Anesthesia Key Company Manufacturing Base & Headquarters Table 12. Global Inhalation Anesthesia Company, Product Type & Application Table 13. Global Inhalation Anesthesia Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Anesthesia by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Isoflurane Table 18. Significant Companies of Sevoflurane Table 19. Significant Companies of Desflurane Table 20. Global Inhalation Anesthesia Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhalation Anesthesia Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Inhalation Anesthesia Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Inhalation Anesthesia Sales Volume Share by Type (2021-2026) Table 24. Global Inhalation Anesthesia Sales Volume Share by Type (2027-2032) Table 25. Global Inhalation Anesthesia Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhalation Anesthesia Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhalation Anesthesia Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhalation Anesthesia Sales Value Share by Type (2021-2026) Table 29. Global Inhalation Anesthesia Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Induction Table 31. Significant Companies of Maintenance Table 32. Global Inhalation Anesthesia Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Inhalation Anesthesia Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Inhalation Anesthesia Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Inhalation Anesthesia Sales Volume Share by Application (2021-2026) Table 36. Global Inhalation Anesthesia Sales Volume Share by Application (2027-2032) Table 37. Global Inhalation Anesthesia Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Inhalation Anesthesia Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Inhalation Anesthesia Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Inhalation Anesthesia Sales Value Share by Application (2021-2026) Table 41. Global Inhalation Anesthesia Sales Value Share by Application (2027-2032) Table 42. Global Inhalation Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Inhalation Anesthesia Sales by Region (2021-2026) & (K Units) Table 44. Global Inhalation Anesthesia Sales Market Share by Region (2021-2026) Table 45. Global Inhalation Anesthesia Sales by Region (2027-2032) & (K Units) Table 46. Global Inhalation Anesthesia Sales Market Share by Region (2027-2032) Table 47. Global Inhalation Anesthesia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Inhalation Anesthesia Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Inhalation Anesthesia Sales Value Share by Region (2021-2026) Table 50. Global Inhalation Anesthesia Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Inhalation Anesthesia Sales Value Share by Region (2027-2032) Table 52. Global Inhalation Anesthesia Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Inhalation Anesthesia Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Inhalation Anesthesia Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Inhalation Anesthesia Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Inhalation Anesthesia Sales by Country (2021-2026) & (K Units) Table 57. Global Inhalation Anesthesia Sales Market Share by Country (2021-2026) Table 58. Global Inhalation Anesthesia Sales by Country (2027-2032) & (K Units) Table 59. Global Inhalation Anesthesia Sales Market Share by Country (2027-2032) Table 60. Global Inhalation Anesthesia Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Inhalation Anesthesia Sales Value Market Share by Country (2021-2026) Table 62. Global Inhalation Anesthesia Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Inhalation Anesthesia Sales Value Market Share by Country (2027-2032) Table 64. Lunan Pharmaceutical Group Co.Ltd. Company Information Table 65. Lunan Pharmaceutical Group Co.Ltd. Business Overview Table 66. Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Product Portfolio Table 68. Lunan Pharmaceutical Group Co.Ltd. Recent Development Table 69. Jiangsu Hengrui Medicine Co. Ltd. Company Information Table 70. Jiangsu Hengrui Medicine Co. Ltd. Business Overview Table 71. Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Product Portfolio Table 73. Jiangsu Hengrui Medicine Co. Ltd. Recent Development Table 74. Fresenius Kabi Ag Company Information Table 75. Fresenius Kabi Ag Business Overview Table 76. Fresenius Kabi Ag Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Fresenius Kabi Ag Inhalation Anesthesia Product Portfolio Table 78. Fresenius Kabi Ag Recent Development Table 79. Baxter Company Information Table 80. Baxter Business Overview Table 81. Baxter Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Baxter Inhalation Anesthesia Product Portfolio Table 83. Baxter Recent Development Table 84. AbbVie Inc. Company Information Table 85. AbbVie Inc. Business Overview Table 86. AbbVie Inc. Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AbbVie Inc. Inhalation Anesthesia Product Portfolio Table 88. AbbVie Inc. Recent Development Table 89. Piramal Enterprises Limited Company Information Table 90. Piramal Enterprises Limited Business Overview Table 91. Piramal Enterprises Limited Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Piramal Enterprises Limited Inhalation Anesthesia Product Portfolio Table 93. Piramal Enterprises Limited Recent Development Table 94. Hikma Pharmaceuticals PLC Company Information Table 95. Hikma Pharmaceuticals PLC Business Overview Table 96. Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hikma Pharmaceuticals PLC Inhalation Anesthesia Product Portfolio Table 98. Hikma Pharmaceuticals PLC Recent Development Table 99. Halocarbon Products Corporation Company Information Table 100. Halocarbon Products Corporation Business Overview Table 101. Halocarbon Products Corporation Inhalation Anesthesia Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Halocarbon Products Corporation Inhalation Anesthesia Product Portfolio Table 103. Halocarbon Products Corporation Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Inhalation Anesthesia Distributors List Table 107. Inhalation Anesthesia Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Inhalation Anesthesia Product Image Figure 2. Global Inhalation Anesthesia Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhalation Anesthesia Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Anesthesia Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhalation Anesthesia Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Isoflurane Image Figure 10. Sevoflurane Image Figure 11. Desflurane Image Figure 12. Global Inhalation Anesthesia Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Inhalation Anesthesia Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhalation Anesthesia Sales Volume Share by Type (2021-2032) Figure 15. Global Inhalation Anesthesia Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhalation Anesthesia Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhalation Anesthesia Sales Value Share by Type (2021-2032) Figure 18. Induction Image Figure 19. Maintenance Image Figure 20. Global Inhalation Anesthesia Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Inhalation Anesthesia Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Inhalation Anesthesia Sales Volume Share by Application (2021-2032) Figure 23. Global Inhalation Anesthesia Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Inhalation Anesthesia Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Inhalation Anesthesia Sales Value Share by Application (2021-2032) Figure 26. Global Inhalation Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Inhalation Anesthesia Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Inhalation Anesthesia Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Inhalation Anesthesia Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 31. North America Inhalation Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Inhalation Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Inhalation Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 37. South America Inhalation Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Inhalation Anesthesia Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Inhalation Anesthesia Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Inhalation Anesthesia Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Inhalation Anesthesia Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Inhalation Anesthesia Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Desflurane
Applications
  • Induction
  • Maintenance
Companies covered
  • Lunan Pharmaceutical Group Co.Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Fresenius Kabi Ag
  • Baxter
  • AbbVie Inc.
  • Piramal Enterprises Limited
  • Hikma Pharmaceuticals PLC
  • Halocarbon Products Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Anesthesia Sales Value (2021-2032)
  4. 1.2.2 Global Inhalation Anesthesia Sales Volume (2021-2032)
  5. 1.2.3 Global Inhalation Anesthesia Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhalation Anesthesia Market Dynamics
  1. 2.1 Inhalation Anesthesia Industry Trends
  2. 2.2 Inhalation Anesthesia Industry Drivers
  3. 2.3 Inhalation Anesthesia Industry Opportunities and Challenges
  4. 2.4 Inhalation Anesthesia Industry Restraints
3 Inhalation Anesthesia Market by Company
  1. 3.1 Global Inhalation Anesthesia Company Revenue Ranking in 2025
  2. 3.2 Global Inhalation Anesthesia Revenue by Company (2021-2026)
  3. 3.3 Global Inhalation Anesthesia Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhalation Anesthesia Average Price by Company (2021-2026)
  5. 3.5 Global Inhalation Anesthesia Company Ranking (2024-2026)
  6. 3.6 Global Inhalation Anesthesia Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhalation Anesthesia Company Product Type and Application
  8. 3.8 Global Inhalation Anesthesia Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhalation Anesthesia Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhalation Anesthesia Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhalation Anesthesia Market by Type
  1. 4.1 Inhalation Anesthesia Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Desflurane
  5. 4.2 Global Inhalation Anesthesia Sales Volume by Type
  6. 4.2.1 Global Inhalation Anesthesia Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Anesthesia Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhalation Anesthesia Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhalation Anesthesia Sales Value by Type
  10. 4.3.1 Global Inhalation Anesthesia Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Anesthesia Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhalation Anesthesia Sales Value Share by Type (2021-2032)
5 Inhalation Anesthesia Market by Application
  1. 5.1 Inhalation Anesthesia Application Introduction
  2. 5.1.1 Induction
  3. 5.1.2 Maintenance
  4. 5.2 Global Inhalation Anesthesia Sales Volume by Application
  5. 5.2.1 Global Inhalation Anesthesia Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inhalation Anesthesia Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Inhalation Anesthesia Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Inhalation Anesthesia Sales Value by Application
  9. 5.3.1 Global Inhalation Anesthesia Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Inhalation Anesthesia Sales Value by Application (2021-2032)
  11. 5.3.3 Global Inhalation Anesthesia Sales Value Share by Application (2021-2032)
6 Inhalation Anesthesia Regional Sales and Value Analysis
  1. 6.1 Global Inhalation Anesthesia Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Anesthesia Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Anesthesia Sales by Region: 2021-2026
  4. 6.2.2 Global Inhalation Anesthesia Sales by Region (2027-2032)
  5. 6.3 Global Inhalation Anesthesia Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhalation Anesthesia Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhalation Anesthesia Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhalation Anesthesia Sales Value by Region (2027-2032)
  9. 6.5 Global Inhalation Anesthesia Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhalation Anesthesia Sales Value (2021-2032)
  12. 6.6.2 North America Inhalation Anesthesia Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhalation Anesthesia Sales Value (2021-2032)
  15. 6.7.2 Europe Inhalation Anesthesia Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhalation Anesthesia Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhalation Anesthesia Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhalation Anesthesia Sales Value (2021-2032)
  21. 6.9.2 South America Inhalation Anesthesia Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhalation Anesthesia Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhalation Anesthesia Sales Value Share by Country, 2025 VS 2032
7 Inhalation Anesthesia Country-level Sales and Value Analysis
  1. 7.1 Global Inhalation Anesthesia Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhalation Anesthesia Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhalation Anesthesia Sales by Country (2021-2032)
  4. 7.3.1 Global Inhalation Anesthesia Sales by Country (2021-2026)
  5. 7.3.2 Global Inhalation Anesthesia Sales by Country (2027-2032)
  6. 7.4 Global Inhalation Anesthesia Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhalation Anesthesia Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhalation Anesthesia Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhalation Anesthesia Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhalation Anesthesia Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhalation Anesthesia Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lunan Pharmaceutical Group Co.Ltd.
  2. 8.1.1 Lunan Pharmaceutical Group Co.Ltd. Company Information
  3. 8.1.2 Lunan Pharmaceutical Group Co.Ltd. Business Overview
  4. 8.1.3 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Product Portfolio
  6. 8.1.5 Lunan Pharmaceutical Group Co.Ltd. Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine Co. Ltd.
  8. 8.2.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
  13. 8.3 Fresenius Kabi Ag
  14. 8.3.1 Fresenius Kabi Ag Company Information
  15. 8.3.2 Fresenius Kabi Ag Business Overview
  16. 8.3.3 Fresenius Kabi Ag Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Ag Inhalation Anesthesia Product Portfolio
  18. 8.3.5 Fresenius Kabi Ag Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Inhalation Anesthesia Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 AbbVie Inc.
  26. 8.5.1 AbbVie Inc. Company Information
  27. 8.5.2 AbbVie Inc. Business Overview
  28. 8.5.3 AbbVie Inc. Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Inc. Inhalation Anesthesia Product Portfolio
  30. 8.5.5 AbbVie Inc. Recent Developments
  31. 8.6 Piramal Enterprises Limited
  32. 8.6.1 Piramal Enterprises Limited Company Information
  33. 8.6.2 Piramal Enterprises Limited Business Overview
  34. 8.6.3 Piramal Enterprises Limited Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Enterprises Limited Inhalation Anesthesia Product Portfolio
  36. 8.6.5 Piramal Enterprises Limited Recent Developments
  37. 8.7 Hikma Pharmaceuticals PLC
  38. 8.7.1 Hikma Pharmaceuticals PLC Company Information
  39. 8.7.2 Hikma Pharmaceuticals PLC Business Overview
  40. 8.7.3 Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Pharmaceuticals PLC Inhalation Anesthesia Product Portfolio
  42. 8.7.5 Hikma Pharmaceuticals PLC Recent Developments
  43. 8.8 Halocarbon Products Corporation
  44. 8.8.1 Halocarbon Products Corporation Company Information
  45. 8.8.2 Halocarbon Products Corporation Business Overview
  46. 8.8.3 Halocarbon Products Corporation Inhalation Anesthesia Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Halocarbon Products Corporation Inhalation Anesthesia Product Portfolio
  48. 8.8.5 Halocarbon Products Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Anesthesia Value Chain Analysis
  2. 9.1.1 Inhalation Anesthesia Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Anesthesia Sales Mode & Process
  6. 9.2 Inhalation Anesthesia Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Anesthesia Distributors
  9. 9.2.3 Inhalation Anesthesia Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst